New hope to slow aggressive bone cancers
NCT ID NCT02389244
Summary
This study is testing whether a drug called regorafenib can help control the growth of advanced bone sarcomas that have spread to other parts of the body. It involves 163 patients with specific types of bone cancer who have already tried other treatments. Participants are randomly assigned to receive either the study drug or a placebo pill, along with standard supportive care, to see if regorafenib can delay cancer progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Bretonneau
Tours, 37000, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugene Marquis
Rennes, 35042, France
-
Centre Francois Baclesse
Caen, 14176, France
-
Centre Georges Francois Leclerc
Dijon, 21079, France
-
Centre Léon Berard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Gustave Roussy
Villejuif, 94800, France
-
Hopital Jean Monjoz
Besançon, 25030, France
-
Hôpital Cochin
Paris, 75014, France
-
ICM Val d'Aurelle
Montpellier, 34298, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Curie
Paris, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie Lucien Neuwirth (ICLN)
Saint-Priest-en-Jarez, 42270, France
-
Institut de cancerologie de l'ouest site Rene Gauducheau
Saint-Herblain, 44805, France
-
Institut de cancerologie de lorraine alexis Vautrin
Vandœuvre-lès-Nancy, 54519, France
-
La Timone University Hospital
Marseille, 13385, France
Conditions
Explore the condition pages connected to this study.